|
|
Volumn 266, Issue 5186, 1994, Pages 801-805
|
|
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
DIDANOSINE;
HYDROXYUREA;
RIBONUCLEOTIDE REDUCTASE;
VIRUS DNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIVIRAL ACTIVITY;
ARTICLE;
DNA SYNTHESIS INHIBITION;
DRUG MECHANISM;
DRUG POTENTIATION;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MACROPHAGE;
PERIPHERAL LYMPHOCYTE;
PRIORITY JOURNAL;
VIRUS INHIBITION;
VIRUS REPLICATION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
CELL SURVIVAL;
DIDANOSINE;
DNA REPLICATION;
DNA, VIRAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SYNERGISM;
HIV CORE PROTEIN P24;
HIV-1;
HUMAN;
HYDROXYUREA;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTE ACTIVATION;
MACROPHAGE ACTIVATION;
MACROPHAGES;
SUPPORT, U.S. GOV'T, P.H.S.;
VIRUS REPLICATION;
ZIDOVUDINE;
DNA VIRUSES;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
|
EID: 0027948936
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.7973634 Document Type: Article |
|
Times cited : (309)
|
|
References (28)
|
